Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Neuroradiology: Page 130
ISMRM 2015: DTI-MRI may show chemo's side effects in kids
By
Wayne Forrest
TORONTO - Diffusion-tensor MRI (DTI-MRI) may demonstrate the side effects of chemotherapy in kids treated for a type of glioma by showing lower levels of fractional anisotropy in white matter in the brain, according to a study presented on Monday at the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting.
May 31, 2015
DTI-MRI may identify early onset of Alzheimer's disease
By
Wayne Forrest
Using diffusion-tensor MRI (DTI-MRI) to identify damaged white matter in the brain may help pinpoint the early onset of Alzheimer's disease, as well as the start of two atypical forms of the condition, according to a new Dutch study published online May 27 in
Radiology
.
May 26, 2015
Autosegmentation algorithm tackles array of brain tumors
By
Eric Barnes
A new algorithm for automatically segmenting image data delivers fast and reproducible volumes of a wide variety of tumors, satisfying a significant unmet need in neuro-oncology, according to a new study in
Academic Radiology
. A panel of readers gave the algorithm high marks for how well it approximated manual data segmentation methods.
May 21, 2015
3T MRI finds brain changes in retired football players
By
AuntMinnie.com staff writers
In the first study of its kind, researchers using 3-tesla MRI found a link between hippocampal volume, memory performance, and concussion severity among 28 former professional football players.
May 19, 2015
Ipsen bids for OctreoPharm
By
AuntMinnie.com staff writers
French biotechnology firm Ipsen has inked an agreement to purchase German radiopharmaceutical developer OctreoPharm Sciences for a total price of up to 50 million euros ($55.7 million U.S.).
May 19, 2015
Analysis finds variance in uptake of amyloid PET tracers
By
Wayne Forrest
PET scans can detect varying levels of amyloid in the brain that change with age and the presence of a genotype linked to Alzheimer's disease, according to a meta-analysis in the May
Journal of the American Medical Association
. The findings may enable clinicians to better tailor which patients receive the scans.
May 18, 2015
Faster access to MRI results in better stroke care
By
AuntMinnie.com staff writers
Two Washington, DC-area hospitals found that improving their workflow led to stroke patients getting clot-busting drugs sooner, along with first-line MR imaging.
May 13, 2015
SPECT differentiates PTSD from TBI in military veterans
By
Wayne Forrest
Add SPECT to the list of imaging modalities that can help physicians distinguish between post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), potentially leading to more appropriate treatment for military veterans.
May 10, 2015
Imaging Biometrics touts ASNR study
By
AuntMinnie.com staff writers
Imaging Biometrics is pointing to favorable results from a study involving its IB Neuro MRI dynamic susceptibility contrast software that was presented at last month's American Society of Neuroradiology (ASNR) meeting in Chicago.
May 6, 2015
Gadolinium contrast retention raises new safety questions
By
Wayne Forrest
A new study by Japanese researchers published on May 5 in
Radiology
confirms previous findings that traces of gadolinium contrast remain in the brains of people who receive contrast-enhanced MRI scans. The results are raising new questions about the safety of gadolinium-based contrast, such as whether the deposits are harmful.
May 4, 2015
MRI shows how cheap wine can taste so good
By
AuntMinnie.com staff writers
It has been said that the best wine is the one that tastes good to you, regardless of price. German researchers put that axiom to the test by investigating whether preconceived ideas about price and quality could actually change brain chemistry.
April 30, 2015
FDA clears St. Jude's MR-conditional spinal stimulation system
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration has cleared St. Jude Medical's Protégé MRI spinal cord stimulation system, as well as the company's 60-cm Octrode percutaneous leads for use with the device.
April 29, 2015
Previous Page
Page 130 of 239
Next Page
